Chalcone Derivatives and their Activities against Drug-resistant Cancers: An Overview

Author(s): Jiaqi Xiao, Meixiang Gao, Qiang Diao*, Feng Gao*

Journal Name: Current Topics in Medicinal Chemistry

Volume 21 , Issue 5 , 2021

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Drug resistance, including multidrug resistance resulting from different defensive mechanisms in cancer cells, is the leading cause of the failure of the cancer therapy, posing an urgent need to develop more effective anticancer agents. Chalcones, widely distributed in nature, could act on diverse enzymes and receptors in cancer cells. Accordingly, chalcone derivatives possess potent activity against various cancers, including drug-resistant, even multidrug-resistant cancer. This review outlines the recent development of chalcone derivatives with potential activity against drug-resistant cancers covering articles published between 2010 and 2020 so as to facilitate further rational design of more effective candidates.

Keywords: Chalcone, Drug resistance, Multi-drug resistance, Anticancer, Mechanism of action, Cytotoxic drug efflux.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2021
Published on: 22 October, 2020
Page: [348 - 362]
Pages: 15
DOI: 10.2174/1568026620666201022143236
Price: $65

Article Metrics

PDF: 34